CLBIO.ST
Price:
$16.7
Market Cap:
$409.00M
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent. The company was founded in 1991 and is based in Uppsala, Sweden.
Industry
Biotechnology
IPO Date
2015-06-03
Stock Exchange
STO
Ticker
CLBIO.ST
According to Corline Biomedical AB’s latest financial reports and current stock price. The company's current ROE is -29.03%. This represents a change of 309.67% compared to the average of -7.09% of the last 4 quarters.
The mean historical ROE of Corline Biomedical AB over the last ten years is -13.42%. The current -29.03% ROE has changed 116.39% with respect to the historical average. Over the past ten years (40 quarters), CLBIO.ST's ROE was at its highest in in the September 2022 quarter at 2.09%. The ROE was at its lowest in in the December 2024 quarter at -16.29%.
Average
-13.42%
Median
-13.77%
Minimum
-27.51%
Maximum
2.46%
Discovering the peaks and valleys of Corline Biomedical AB ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.28%
Maximum Annual ROE = 2.46%
Minimum Annual Increase = -178.73%
Minimum Annual ROE = -27.51%
| Year | ROE | Change |
|---|---|---|
| 2024 | -26.69% | 1.28% |
| 2023 | -1.94% | -178.73% |
| 2022 | 2.46% | -132.84% |
| 2021 | -7.50% | -46.46% |
| 2020 | -14.00% | -12.92% |
| 2019 | -16.08% | 30.13% |
| 2018 | -12.36% | -27.32% |
| 2017 | -17.01% | 25.55% |
| 2016 | -13.54% | -50.76% |
| 2015 | -27.51% | -39.95% |
The current ROE of Corline Biomedical AB (CLBIO.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.72%
5-year avg
-9.53%
10-year avg
-13.42%
Corline Biomedical AB’s ROE is greater than Magle Chemoswed Holding AB (publ) (-4.90%), greater than Mendus AB (publ) (-17.05%), greater than Enzymatica AB (publ) (-35.29%), greater than Elicera Therapeutics AB (publ) (-45.82%), greater than Ascelia Pharma AB (publ) (-102.90%), greater than FluoGuide A/S (-341.29%), less than Xintela AB (publ) (245.05%), greater than Intervacc AB (publ) (-22.21%), greater than Bactiguard Holding AB (publ) (-6.77%), greater than Bio-Works Technologies AB (publ) (-84.51%),
| Company | ROE | Market cap |
|---|---|---|
| -4.90% | $353.10M | |
| -17.05% | $257.32M | |
| -35.29% | $428.43M | |
| -45.82% | $266.46M | |
| -102.90% | $354.32M | |
| -341.29% | $490.32M | |
| 245.05% | $178.65M | |
| -22.21% | $301.96M | |
| -6.77% | $648.23M | |
| -84.51% | $184.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corline Biomedical AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Corline Biomedical AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Corline Biomedical AB's ROE?
How is the ROE calculated for Corline Biomedical AB (CLBIO.ST)?
What is the highest ROE for Corline Biomedical AB (CLBIO.ST)?
What is the 3-year average ROE for Corline Biomedical AB (CLBIO.ST)?
What is the 5-year average ROE for Corline Biomedical AB (CLBIO.ST)?
How does the current ROE for Corline Biomedical AB (CLBIO.ST) compare to its historical average?